Mauricio Urresta

Investment Analyst at British Patient Capital

Mauricio Urresta has a diverse work experience spanning various industries. Mauricio started their career as a Shop Assistant volunteer at the British Heart Foundation in 2013. In 2016, they worked as an Accounting Intern at Caterpillar Financial Services Corporation, gaining valuable experience in finance and accounting. Mauricio then joined Santander UK as a Customer Service Advisor, focusing on building customer loyalty and meeting their needs. In 2018, they interned at Meliá Hotels International in the Real Estate department, where they worked on joint ventures and collaborated with various departments. In 2020, they joined HSBC as a Credit Officer - Underwriter, before transitioning to roles as Business Readiness Officer and later as a Business Readiness Manager (Portfolio Lead). Currently, they are an Investment Analyst at British Patient Capital, where they utilize their analytical skills in the investment field.

Mauricio Urresta attended East Durham College from 2015 to 2016, where they focused on the field of study of Business and Enterprise. In 2016, they enrolled in Sheffield Hallam University and completed their Bachelor of Arts (BA) degree in Business Management and Enterprise in 2020. During their education, Urresta obtained additional certifications, such as Microsoft Office Excel from Microsoft in March 2017 and the IFS Student Investor Challenge from The London Institute of Banking & Finance in October 2013.

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


British Patient Capital

British Patient Capital invests in a diversified portfolio of best-in-class venture and growth capital funds and start ups, capturing value through financing the growth of innovative companies. We invest on a commercial basis to deliver competitive returns and manage risk.As well as providing our own funding we work to encourage more investors tomake allocations to this asset class by demonstrating that a long-term patient capital investment strategy can produce commercially attractive returns.Once we’ve established a strong record, and have proved the value of the asset class, we intend to privatise British Patient Capital at an appropriate time in the future.